{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:04:10Z","timestamp":1789769050486,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.htct.2026.106536","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:50:40Z","timestamp":1789768240000},"page":"106536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ophthalmological and epidemiological profiles of Brazilian patients with philadelphia-negative Myeloproliferative neoplasms"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3839-4717","authenticated-orcid":false,"given":"R\u00f4mulo","family":"Piloni-Parreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melaine Stefane","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds Lauria","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernani Lopes","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Marcos Ranyere da Silva","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Sampaio","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Leonardo Cruvinel","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Pereira de \u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.htct.2026.106536_bib0001","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/hematology.2024000576","article-title":"Molecular profiling in MPN: who should have it and why?","volume":"2024","author":"Chee","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.htct.2026.106536_bib0002","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/cancers12030573","article-title":"Ocular manifestations in patients with philadelphia-negative myeloproliferative neoplasms","volume":"12","author":"Liisborg","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.htct.2026.106536_bib0003","article-title":"Ocular manifestations in hematological disorders","volume":"14","author":"Bouazza","year":"2022","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.htct.2026.106536_bib0004","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00347-011-2430-x","article-title":"Augenver\u00e4nderungen bei h\u00e4matologischen Erkrankungen [Ocular findings in hematological diseases]","volume":"108","author":"Lang","year":"2011","journal-title":"Ophthalmologe"},{"issue":"2","key":"10.1016\/j.htct.2026.106536_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/hematolrep16020020","article-title":"Ophthalmic manifestations in patients with blood malignancies","volume":"16","author":"Rossi","year":"2024","journal-title":"Hematol Rep."},{"issue":"6","key":"10.1016\/j.htct.2026.106536_bib0006","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000073077","article-title":"Ocular involvement in leukemia\u2013a study of 288 cases","volume":"217","author":"Reddy","year":"2003","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1016\/j.htct.2026.106536_bib0007","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2008-03-143602","article-title":"Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden","volume":"112","author":"Landgren","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2026.106536_bib0008","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","article-title":"Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms","volume":"128","author":"Hinds","year":"2016","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.htct.2026.106536_bib0009","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjh.18650","article-title":"Characterization of myeloproliferative neoplasms in the pediatric and young adult population","volume":"201","author":"Harris","year":"2023","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.htct.2026.106536_bib0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.14061","article-title":"Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic\/myeloproliferative neoplasms in the United States, 2001-12","volume":"174","author":"Srour","year":"2016","journal-title":"Br J Haematol"},{"issue":"17","key":"10.1016\/j.htct.2026.106536_bib0011","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1200\/JCO.2018.78.9867","article-title":"MIPSS70+ version 2.0: mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis","volume":"36","author":"Tefferi","year":"2018","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.htct.2026.106536_bib0012","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1200\/JCO.2010.30.5128","article-title":"Adolescent and young adult oncology: an emerging field","volume":"28","author":"Thomas","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.htct.2026.106536_bib0013","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/S2352-3026(22)00330-1","article-title":"Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a position paper on behalf of the chronic malignancies working party of the EBMT","volume":"10","author":"Polverelli","year":"2023","journal-title":"Lancet Haematol"},{"issue":"16","key":"10.1016\/j.htct.2026.106536_bib0014","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood.2023020232","article-title":"Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL","volume":"143","author":"Gerds","year":"2024","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.htct.2026.106536_bib0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumors: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.htct.2026.106536_bib0016","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11899-014-0228-z","article-title":"Epidemiology of MPN: what do we know?","volume":"9","author":"Anderson","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"issue":"9","key":"10.1016\/j.htct.2026.106536_bib0017","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/cancers16091679","article-title":"Advances in molecular understanding of polycythemia vera, essential thrombocythemia, and primary myelofibrosis: towards precision medicine","volume":"16","author":"Tashkandi","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.htct.2026.106536_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00428-022-03465-7","article-title":"Advances in myelodysplastic\/myeloproliferative neoplasms","volume":"482","author":"Prakash","year":"2023","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.htct.2026.106536_bib0019","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-017-0425-z","article-title":"Driver mutations (JAK2V617F, MPLW515L\/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera","volume":"10","author":"Lussana","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"24","key":"10.1016\/j.htct.2026.106536_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417383","article-title":"Myeloproliferative neoplasms: contemporary review and molecular landscape","volume":"24","author":"Mahmud","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"25","key":"10.1016\/j.htct.2026.106536_bib0021","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.htct.2026.106536_bib0022","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jamaophthalmol.2017.2011","article-title":"Age-related macular degeneration in patients with chronic myeloproliferative neoplasms","volume":"135","author":"Bak","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"42","key":"10.1016\/j.htct.2026.106536_bib0023","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.htct.2026.106536_bib0024","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2024.20377","article-title":"Diagnosis and treatment of polycythemia vera: a review","volume":"333","author":"Tremblay","year":"2025","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.htct.2026.106536_bib0025","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s11864-024-01255-8","article-title":"Myeloproliferative neoplasms and cardiovascular disease: a review","volume":"25","author":"Leiva","year":"2024","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"10.1016\/j.htct.2026.106536_bib0026","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaapos.2012.04.006","article-title":"Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates","volume":"16","author":"Goel","year":"2012","journal-title":"J AAPOS"},{"issue":"4","key":"10.1016\/j.htct.2026.106536_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.70088","article-title":"Bleeding complications in JAK2-variant essential thrombocythemia: a revisit in 2025","volume":"6","author":"Gurumurthy","year":"2025","journal-title":"EJHaem"},{"issue":"5","key":"10.1016\/j.htct.2026.106536_bib0028","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.12290","article-title":"Delayed choroidal and retinal blood flow in polycythaemia vera patients with transient ocular blindness: a preliminary study with fluorescein angiography","volume":"161","author":"Yang","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.htct.2026.106536_bib0029","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12886-022-02423-w","article-title":"Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report","volume":"22","author":"Regensburger","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.htct.2026.106536_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1167\/iovs.66.2.41","article-title":"High levels of C5a are associated with reduced macular sensitivity in patients with myeloproliferative neoplasms","volume":"66","author":"Gotfredsen","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792600283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792600283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:50:44Z","timestamp":1789768244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253113792600283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S253113792600283X"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106536","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophthalmological and epidemiological profiles of Brazilian patients with philadelphia-negative Myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106536"}}